Formoterol fumarate 12 mcg Inhalation Powder
RxNorm 1246326
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1246326 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: formoterol fumarate 12 mcg Inhalation Powder.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Formoterol fumarate 0.012 mg Inhalation Powder
(Atom ID: 10788769)
PSN
Prescribable Name (PSN):
Formoterol fumarate 12 mcg Inhalation Powder
(Atom ID: 10788547)
SY
Synonym (SY):
Formoterol fumarate 12 mcg Inhalation Powder
(Atom ID: 10788548)
PT
Designated preferred name (PT):
Formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation
(Atom ID: 10298946)
FN
Full form of descriptor (FN):
Product containing precisely formoterol fumarate dihydrate 12 microgram/1 actuation conventional release powder for inhalation (clinical drug)
(Atom ID: 11439966)
Patient Education
Formoterol Oral Inhalation
Formoterol oral inhalation is used to control wheezing, shortness of breath, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). Formoterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.